Dr. Sanjay Bhargava, M.D.
What this data tells you about Dr. Bhargava
Dr. Sanjay Bhargava is a cardiovascular disease in Fort Worth, TX, with 19 years in practice. Based on federal Medicare data, Dr. Bhargava performed 2,013 Medicare services across 1,574 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bhargava received a total of $3,811 from 28 pharmaceutical and/or device companies across 133 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bhargava is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 348 | $88 | $234 |
| Regadenoson injection (Lexiscan) for heart stress test | 208 | $39 | $120 |
| Hospital follow-up visit, moderate complexity | 194 | $61 | $153 |
| Electrocardiogram (EKG), 12-lead | 187 | $10 | $42 |
| EKG interpretation and report | 152 | $6 | $121 |
| Initial hospital admission, high complexity | 105 | $135 | $434 |
| Hospital follow-up visit, high complexity | 101 | $88 | $222 |
| Echocardiogram, transthoracic | 74 | $136 | $469 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 59 | $48 | $196 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 55 | $334 | $1,094 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 54 | $139 | $227 |
| Office visit, established patient (20-29 min) | 53 | $63 | $171 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 46 | $10 | $150 |
| New patient office visit (45-59 min) | 44 | $113 | $357 |
| Ultrasonic guidance for blood vessel access | 43 | $11 | $22 |
| Cardiac catheterization | 39 | $187 | $668 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 28 | $20 | $74 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 27 | $659 | $900 |
| Hospital follow-up visit, low complexity | 26 | $39 | $85 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 24 | $2 | $30 |
| Coronary stent placement | 21 | $396 | $1,271 |
| Ultrasound of heart, follow-up | 19 | $19 | $102 |
| Ultrasound of both sides of head and neck blood flow | 19 | $146 | $554 |
| Critical care, first 30-74 min | 17 | $166 | $590 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $83 | $239 |
| Ultrasound of heart blood flow, valves and chambers | 15 | $14 | $42 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 14 | $6 | $14 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 13 | $121 | $538 |
| Initial hospital admission, moderate complexity | 13 | $99 | $269 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bhargava is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bhargava experienced with office visit, established patient (30-39 min)?
Does Dr. Bhargava receive payments from pharmaceutical companies?
How do Dr. Bhargava's costs compare to other cardiovascular diseases in Fort Worth?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology